Conjugated malaria vaccine
Ended Awarded Last action
- Contract number
- HHSN26100050
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,038,624
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $5,038,624.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Change Order | $1,960,359 | |
| Other Administrative Action | $0 | |
| Original award | $3,078,265 |
About this award
This is a $5,038,624.00 cost-plus-fixed-fee delivery order contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Leidos Biomedical Research Inc. for the development of a conjugated malaria vaccine. The work will be performed at Fort Detrick, MD with a completion date of September 20, 2023. Leidos Biomedical Research is a subsidiary of Leidos Holdings, Inc. and has provided a range of research, development, and production services in support of federal biomedical research programs at NIH. Major subcontractors on this effort include Repligen Corporation, which is supplying various bioprocessing equipment, and Wyatt Technology Corporation, which is providing specialized materials characterization instrumentation. This contract does not utilize any set-aside designations.
Quick answers
Who was awarded contract HHSN26100050?
HHSN26100050 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 20, 2017.
How much is contract HHSN26100050 worth?
The government has obligated $5,038,624 on HHSN26100050.
Which agency awarded contract HHSN26100050?
National Cancer Institute (National Institutes of Health) awarded HHSN26100050, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract HHSN26100050 an order under another contract?
Yes. HHSN26100050 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract HHSN26100050 competed?
The extent of competition for HHSN26100050 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award